Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ Journal Article
| Authors: | Ettinger, D. S.; Bepler, G.; Bueno, R.; Chang, A.; Chang, J. Y.; Chirieac, L. R.; D'Amico, T. A.; Demmy, T. L.; Feigenberg, S. J.; Grannis, F. W. Jr; Jahan, T.; Jahanzeb, M.; Kessinger, A.; Komaki, R.; Kris, M. G.; Langer, C. J.; Le, Q. T.; Martins, R.; Otterson, G. A.; Robert, F.; Sugarbaker, D. J.; Wood, D. E. |
| Article Title: | Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ |
| Abstract: | Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | immunohistochemistry; cancer chemotherapy; cancer survival; cancer surgery; clinical trial; histopathology; neutropenia; pathogenesis; review; cancer recurrence; cigarette smoking; bevacizumab; cisplatin; erlotinib; area under the curve; cancer growth; cancer risk; dose response; hypertension; treatment planning; unspecified side effect; united states; gemcitabine; paclitaxel; cancer adjuvant therapy; cancer radiotherapy; chemotherapy; topotecan; cancer staging; cancer diagnosis; physician's practice patterns; carboplatin; cancer prevention; metastasis; etoposide; bleeding; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; cancer screening; lung cancer; nccn clinical practice guidelines; drug effect; ifosfamide; vinblastine; docetaxel; irinotecan; pneumonia; cause of death; drug fatality; health planning guidelines; systematic review; family history; cell damage; medical oncology; recurrent disease; radiation therapy; lung alveolus cell carcinoma; targeted therapy; radon; cancer classification; navelbine; mitomycin; pemetrexed; non-small cell lung cancer; meta analysis; environmental exposure; nickel; epidermal growth factor receptor kinase inhibitor; clinical examination; hemoptysis; carcinogen; multimodality therapy; asbestos; polycyclic aromatic hydrocarbon; lung tuberculosis; thoracic surgery; organic compound; hospitals, community; chromium; arsenic derivative; bis(chloromethyl) ether; radium 226; airborne particle |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 4 |
| Issue: | 6 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2006-07-01 |
| Start Page: | 548 |
| End Page: | 582 |
| Language: | English |
| PUBMED: | 16813724 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 62" - "Export Date: 4 June 2012" - "Source: Scopus" |
